Therapeutic Equivalency Clinical Trial
Official title:
Bioequivalence Study of Vigabatrin ORPHELIA Pharma 500mg Soluble Tablets and SabrilTM 500mg Granules for Oral Administration
Methodology:
The study was an open label, randomized, crossover, 2 periods study in 20 healthy male/female
volunteers. Subjects received 500 mg of the new formulation of soluble tablets vigabatrin or
Sabril, as single oral administration in 2 different study periods depending on the
randomization, with a 7-days wash out period between administrations
Objectives:
Primary objective:
Evaluate bioequivalence between a new paediatric formulation of vigabatrin (VGB-ST) and
Sabril granules for oral administration.
Secondary objective:
- Define pharmacokinetic parameters of the new paediatric formulation soluble tablets of
vigabatrin (VGB-ST)
- Assess the safety of the new formulation of soluble tablets VGB-ST versus Sabril
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04467346 -
Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules
|
Phase 1 | |
| Completed |
NCT00807118 -
Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect
|
Phase 1 | |
| Withdrawn |
NCT01405170 -
A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions
|
Phase 1 | |
| Completed |
NCT04885660 -
Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT05786339 -
Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00709189 -
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
|
Phase 1 | |
| Completed |
NCT00658541 -
Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets
|
Phase 1 | |
| Completed |
NCT00685165 -
Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets
|
Phase 1 | |
| Completed |
NCT00997789 -
Bioequivalence of Rebamipide in Korean
|
N/A | |
| Completed |
NCT00684762 -
Fasted Bioavailability Study of Cilostazol Tablets, 100 mg
|
Phase 1 | |
| Recruiting |
NCT04814589 -
Bioequivalence of Ezetimibe Tablets in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03631316 -
Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir
|
N/A | |
| Recruiting |
NCT04438720 -
Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT01359163 -
A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female Subjects
|
Phase 1 | |
| Completed |
NCT00650221 -
Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00648544 -
Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects
|
Phase 1 | |
| Completed |
NCT05225974 -
A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
|
Phase 1 | |
| Withdrawn |
NCT01405131 -
A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets
|
Phase 1 | |
| Withdrawn |
NCT01405157 -
A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions
|
Phase 1 | |
| Completed |
NCT05282940 -
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
|
Phase 1 |